The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Genetic Technologies Limited(NASDAQ:GENE) 
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary ...
Genetic Technologies Days Payable Outstanding ttm (DPO)
Genetic Technologies Days Receivable Outstanding ttm (DSO)
Genetic Technologies Days Inventory Outstanding ttm (DIO)
Genetic Technologies Op Cashflow Per Share ttm
Genetic Technologies Free Cashflow Per Share ttm
Genetic Technologies Cash Per Share ttm
Genetic Technologies P/S ratio ttm
Genetic Technologies (GAAP) P/E ratio ttm
Genetic Technologies P/B ratio ttm
No extra charts and metrics for this ticker.